Browsing by Subject "hepatitis C"

Now showing items 1-6 of 6

    • Article  

      Hepatitis C infection among intravenous drug users attending therapy programs in Cyprus 

      Demetriou, Victoria L.; Van De Vijver, D. A. M. C.; Hezka, Johana; Kostrikis, Leontios G.; Savvopoulou, Natasa; Georgiades, Neoklis; Charilaou, Charis C.; Argyriou, Argyris; Pavlou, Tina; Platritis, Kyriakos; Veresies, Kyriakos L. (2010)
      The most high-risk population for HCV transmission worldwide today are intravenous drug users. HCV genotypes in the general population in Cyprus demonstrate a polyphyletic infection and include subtypes associated with ...
    • Article  

      Hepatitis C virus infection epidemiology among people who inject drugs in europe: A systematic review of data for scaling up treatment and prevention 

      Wiessing, L.; Ferri, M.; Grady, B.; Kantzanou, M.; Sperle, I.; Cullen, K. J.; Hatzakis, Angelos E.; Prins, M.; Vickerman, P.; Lazarus, J. V.; Hope, V. D.; Matheï, C.; Busch, M.; Bollaerts, K.; Bogdanova, V.; Nesheva, E.; Fotsiou, N.; Kostrikis, Leontios G.; Mravčík, V.; Řehák, V.; Částková, J.; Hobstová, J.; Nechanská, B.; Fouchard, J.; Abel-Ollo, K.; Tefanova, V.; Tallo, T.; Brummer-Korvenkontio, H.; Brisacier, A. -C; Michot, I.; Jauffret-Roustide, M.; Zimmermann, R.; Fotiou, A.; Gazdag, G.; Tarján, A.; Galvin, B.; Thornton, L.; Cruciani, M.; Basso, M.; Karnite, A.; Caplinskiene, I.; Lopes, S.; Origer, A.; Melillo, J.; Camilleri, M.; Demanuele, C. O.; Croes, E.; Op De Coul, E.; Rosińska, M.; Struzik, M.; Martins, M.; Duran, D.; Vilar, G.; Resende, M. E.; Martins, H. C.; Abagiu, A. O.; Ruta, S.; Arama, V.; Kopilovic, B.; Kustec, T.; Klavs, I.; Aleixandre, N. L.; Folch, C.; Bravo, M. J.; Gómez, R. S.; Berglund, T.; Strandberg, J.; Hotho, D.; Van Houdt, S.; Low, A.; Mcdonald, B.; Platt, L.; Kalamara, E.; Giraudon, I.; Groshkova, T.; Palladino, C.; Hutchinson, S.; Ncube, F.; Eramova, I.; Goldberg, D.; Vicente, J.; Griffiths, P. (2014)
      Background: People who inject drugs (PWID) are a key population affected by hepatitis C virus (HCV). Treatment options are improving and may enhance prevention
    • Article  

      Meet the editorial board members 

      Kostrikis, Leontios G.; Koka, P. (2015)
    • Article  

      Molecular epidemiology of hepatitis C infection in cyprus: Evidence of polyphyletic infection 

      Demetriou, Victoria L.; Van De Vijver, D. A. M. C.; Kostrikis, Leontios G.; Chimonides, S.; Evgeniou, N. A.; Hadjigeorgiou-Vounou, E.; Koliou-Mazeri, M.; Papakyriakou, P.; Petsas, L.; Potamitis, G. (2009)
      The genetic diversity of the hepatitis C virus (HCV) in Cyprus is investigated for the first time in this study. Nucleotide sequence analysis of the CORE-E1 and NS5B regions of the HCV genome was performed on blood plasma ...
    • Article  

      Near-full genome characterization of unclassified hepatitis c virus strains relating to genotypes 1 and 4 

      Demetriou, Victoria L.; Kostrikis, Leontios G. (2011)
      Near-full genome sequences are presented in this report for the first time of unclassified HCV strains amplified using RT-PCR from plasma of patients living in Cyprus. One strain appears to be a unique genotype-1-like ...
    • Article  

      RNA intereference: A powerful laboratory tool and its therapeutic implications 

      Felekkis, Kyriacos N.; Constantinou-Deltas, Constantinos D. (2006)
      Ever since RNA intereference (RNAi) was discovered in the early 1990s, a number of scientists from the academic and biotechnology world have continued to view it as the revolutionary discovery of the century. Unequivocally, ...